News: Dexa Medica
1 September 2021
Dexa Group Ramps Up Business in SE Asia by Launching Glorious Dexa Singapore Pte. Ltd.
Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to various countries starting with Myanmar since 1993 and began exporting international standard medicines to Singapore…
2 August 2021
Regdanvimab Reduced The Risk of COVID-19-related Hospitalization or Death for Patients with Comorbidities
Regdanvimab (RegkironaTM) is recommended to treat confirmed COVID-19 in adult patients who do not require supplemental oxygen therapy and are at high risk of progressing to severe COVID-19. The recommended dosage of Regdanvimab is a single intravenous infusion of 40 mg/kg. Treatment should be initiated as soon as possible after…
4 June 2021
Dexa Medica Launches Konos: Double Attack Agains Cold and Cough
Dexa Medica, a leading multinational pharmaceutical company in Indonesia through its Nigerian distribution partner Orange Drugs Ltd launches a very effective and highly recommended cold and cough brand named Konos. Konos, aimed at providing relief from cold and cough disturbing and interrupting the daily lives and activities of Nigerians. At…
11 May 2021
Increasingly Global, OMAI HerbaKOF Enters Nigerian Market with the Name HerbaCough
Dexa Medica made a breakthrough in Nigeria by launching the country's first herbal cough medicine, HerbaCough. According to the Country Manager of Dexa Medica Nigeria and West Africa, Mr. Dhanang Anggoro, so far in the country there have been many cough medicines made from chemicals. "Currently, there are many chemical…
30 April 2021
ASIMOR Supports the Success of Exclusive Breastfeeding
Entering the month of Ramadan, breastfeeding mothers or mothers are often hit by concerns regarding the adequacy of milk production needed by the baby. Even though this can be overcome by making a number of preparations so that even though they are fasting, the quality and quantity of breast milk…
13 April 2021
Indonesia Indigenous Modern Medicine from Dexa Group is increasingly known to the world through Hannover Messe 2021
Indonesia is the Official Partner Country in the 2021 Hannover Messe. During the 72 years of holding the Hannover Messe, the health sector appeared for the first time this year and Dexa Group took part. Dexa Group carries the proud product of the innovation of the nation's children, Indonesia Indigenous…
7 April 2021
Indonesian National Police and Health Workers Get Vaccines and Maintain Body Immune
Police officers and health workers as the front line in the implementation of the Covid-19 vaccine need to get maximum protection. In addition to using personal protective equipment (PPE) and implementing health protocols, maximum protection for the body's immune system also needs to be sought. Commercial Director of PT Dexa…
1 April 2021
Stimuno Receives Indonesia Best Pharmacy Brand Award 2021
Over the last 17 years, based on the Marketing Authorization Number (NIE) registered in the National Agency of Drugs and Food Control (BPOM), Indonesia records 23 traditional medicines classified as phytopharmaceuticals. Stimuno has been one of the first phytopharmaceuticals in the country since 2005. Being the authentic Indonesian immunomodulatory product…
26 March 2021
Deputy Minister of Health: OMAI Must Be in the JKN E-Catalog Listing
The support for Indonesia Indigenous Modern Medicine (OMAI) to be included in the National Health Insurance (JKN) program continues to be supported. This support surfaced in the 2nd Webinar Series held by the University of Indonesia Board of Trustees (MWA UI) with the theme "Indonesian Health Resilience and Independence" on…
26 March 2021
Dexa Award Science Scholarship 2021: Indonesia Needs More Health Scientist
Indonesia needs more scientist in the health sector to address various health problems, especially related to the Covid-19 pandemic. For information, the total number of researchers in Indonesia is still minimal. According to the 2017-2045 National Research Master Plan, currently, there are only 80 researchers per 1 million population, while…
